Inactive
G

Genmab

Develops and licenses antibody cancer therapeutics

Global Data & Governance Intern

Data Management +1Posted on May 2
Internship · Summer 2026Princeton, NJ, USANo salary listed

About the Job

Requirements

  • Currently pursuing a Bachelor’s or Master’s degree.
  • Major in Computer Science, Computer Engineering, Data Science, Business Information Management, Information Technology, or a related field.
  • Proficiency in SQL, Python, Spark, R, and HTML.
  • Familiarity with AI and analytics concepts.
  • Strong understanding of data modeling and data analytics.
  • Excellent problem-solving skills.
  • Effective written and verbal communication skills.

Responsibilities

  • Collaborate with stakeholders to understand project requirements and objectives.
  • Design and implement solutions using technologies such as SQL, Python, Spark, R, HTML, AI, and analytics tools.
  • Perform data analysis using SQL, Python or R to derive insights and catalog the data.
  • Support data governance initiatives (e.g., defining data standards, create data/process flow maps, documenting SOPs, and helping initiate and curate entries in the enterprise data catalog).
  • Contribute to real-impact projects that support the organization’s strategic goals.
  • Participate in personal and professional development sessions with business owners and leaders.
  • Work both independently and collaboratively to achieve project milestones.
  • Present findings, outcomes, and key learnings to stakeholders at the conclusion of the internship.

Desired Qualifications

  • Self-disciplined and proactive, with the ability to work independently as well as collaboratively within a team.

About the Company

Genmab

Develops and licenses antibody cancer therapeutics

Genmab develops antibody-based therapies to treat cancer. The company discovers, develops, and commercializes proprietary antibody technologies and treatments designed to target and kill cancer cells, often in collaboration with other biotech or pharmaceutical partners. Its products work by using antibodies that recognize specific cancer cell markers, helping the immune system or the drugs attack and destroy those cells. Genmab differentiates itself through its own patented antibody platforms and its focus on strategically partnering for development and commercialization, allowing it to leverage scientific expertise and shared resources rather than relying on a single product. The company aims to turn scientific insights into approved cancer medicines that improve patient outcomes while building value through licensing deals and collaborations with researchers and drug developers around the world.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Copenhagen, Denmark
Founded
1999

Recently Posted Jobs

Explore more opportunities at Genmab

See more jobs